找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Anticancer Materia Medica; William C.S. Cho Book 2011 Springer Science+Business Media B.V. 2011 Anticancer drug.Complementa

[復(fù)制鏈接]
樓主: Monsoon
51#
發(fā)表于 2025-3-30 08:33:05 | 只看該作者
52#
發(fā)表于 2025-3-30 15:51:52 | 只看該作者
53#
發(fā)表于 2025-3-30 20:07:41 | 只看該作者
An Evidence-based Perspective of , (Lucid Ganoderma) for Cancer Patients,anticancer effects of lucid ganoderma in cell and animal models could be the strong references for the clinical trials. The components with anticancer potential in lucid ganoderma include triterpenoids, steroids, polysaccharides, fatty acids, and novel proteins such as LZ-8. On the basis of . and .
54#
發(fā)表于 2025-3-30 21:47:58 | 只看該作者
An Evidence-based Perspective of , (Multicolored Polypore Mushroom) for Cancer Patients, possible applications for supportive cancer care and therapy. Modulation of innate and adaptive immunity, hematopoietic activity, and direct cytotoxic effects are reviewed with detailed analysis of molecular targets and signaling pathways affected by mushroom components and/or secondary metabolites
55#
發(fā)表于 2025-3-31 01:45:50 | 只看該作者
An Evidence-based Perspective of , (Shiitake Mushroom) for Cancer Patients,tive strategy to control and ultimately overcome cancer. Here, we will summarize the antitumor activity and immunomodulating action of biologically active polysaccharides, mostly β-glucans, from shiitake mushroom fruit bodies and/or cultured mycelium based on experimental and clinical findings. The
56#
發(fā)表于 2025-3-31 06:44:19 | 只看該作者
57#
發(fā)表于 2025-3-31 09:32:19 | 只看該作者
58#
發(fā)表于 2025-3-31 16:52:25 | 只看該作者
59#
發(fā)表于 2025-3-31 20:33:34 | 只看該作者
An Evidence-based Perspective of Herbal Remedies for Cancer Patients,efore acceptance of herbal remedies into wide scale clinical use can be achieved, two critical issues need to be addressed; these include a clearer understanding of their precise mechanism of action, along with supporting empirical clinical data on efficacy. In this chapter, firstly, we describe the
60#
發(fā)表于 2025-4-1 01:31:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 13:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
陆河县| 横山县| 溆浦县| 徐水县| 永寿县| 那坡县| 锡林郭勒盟| 聂荣县| 铜陵市| 黑河市| 安徽省| 织金县| 富源县| 波密县| 南木林县| 景洪市| 田东县| 遵义市| 思南县| 阳江市| 东阿县| 沙洋县| 东至县| 马鞍山市| 双辽市| 湖南省| 宜宾县| 浪卡子县| 策勒县| 崇义县| 奈曼旗| 二连浩特市| 湖口县| 永修县| 彩票| 冷水江市| 尤溪县| 富平县| 土默特左旗| 城口县| 清河县|